Literature DB >> 9592786

Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.

J P Hubble1, J H Kurth, S L Glatt, M C Kurth, G D Schellenberg, R E Hassanein, A Lieberman, W C Koller.   

Abstract

We had previously examined environmental, sociodemographic and clinical variables as predictors for Parkinson's disease with dementia (PD + D) and found that lower educational attainment, greater motor impairment and advanced age at disease onset were more common in PD + D than in subjects with Parkinson's disease without dementia (PD-D). We now explore the hypothesis that genetic traits coupled with nongenetic factors may raise the risk of development of PD + D. The study cohort of 43 PD + D and 51 PD-D subjects was analyzed examining environmental, sociodemographic and clinical variables along with 3 candidate gene markers: poor debrisoquine metabolizer allele (CYP 2D6 29B+), monoamine oxidase B allele 1, and apolipoprotein E epsilon 4 allele. Variables were initially entered into a multivariate model singly. Again lower education, age at onset and motor impairment appeared as predictors of PD + D while other variables (including allele status) failed to emerge as significant individual risk factors for dementia. We then examined environmental and genetic variables analyzed in tandem to look for potential variable interactions. Subjects who had pesticide exposure and at least 1 copy of the CYP 2D6 29B+ allele had 83% predicted probability of PD + D (stepwise logistic regression model: p = 0.0491). This case-control study provides preliminary evidence that a gene-toxin interaction may play an etiological role in PD + D. Further assessment of the role of these putative risk factors in incident dementia in PD is indicated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592786     DOI: 10.1159/000026159

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  Identifying and managing adverse environmental health effects: 4. Pesticides.

Authors:  Margaret D Sanborn; Donald Cole; Alan Abelsohn; Erica Weir
Journal:  CMAJ       Date:  2002-05-28       Impact factor: 8.262

Review 2.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

3.  Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis.

Authors:  Stewart A Factor; N Kyle Steenland; Donald S Higgins; Eric S Molho; Denise M Kay; Jennifer Montimurro; Ami R Rosen; Cyrus P Zabetian; Haydeh Payami
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-30       Impact factor: 10.154

Review 4.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

5.  Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells.

Authors:  Naomi Matoh; Seigo Tanaka; Masanori Takehashi; Marek Banasik; Todd Stedeford; Eliezer Masliah; Shigehiko Suzuki; Yoshihiko Nishimura; Kunihiro Ueda
Journal:  Gene Expr       Date:  2003

Review 6.  Non-cancer health effects of pesticides: systematic review and implications for family doctors.

Authors:  M Sanborn; K J Kerr; L H Sanin; D C Cole; K L Bassil; C Vakil
Journal:  Can Fam Physician       Date:  2007-10       Impact factor: 3.275

Review 7.  Association of pesticide exposure with neurologic dysfunction and disease.

Authors:  Freya Kamel; Jane A Hoppin
Journal:  Environ Health Perspect       Date:  2004-06       Impact factor: 9.031

8.  CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.

Authors:  Yu Lu; Cuiju Mo; Zhiyu Zeng; Siyuan Chen; Yantong Xie; Qiliu Peng; Yu He; Yan Deng; Jian Wang; Li Xie; Jie Zeng; Shan Li; Xue Qin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.